Andrew McLachlan

Has grant

Professor of Pharmacy

University of Sydney

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

ORCID

Google Scholar

Academic Page

About

Professor Andrew McLachlan is a faculty member at the University of Sydney, Australia. His research areas include pharmacotherapy, with a focus on clinical effectiveness and safety in oncology, pain management, and community pharmacy practices. His recent publications discuss topics such as neuropathic cancer pain treatment, medicine disposal interventions, and the impact of natural products on drug interactions. Committed to advancing pharmacy practice, he also explores conscientious objection in healthcare settings.

Recent Grants

Grant: Close

Patient-centred eHealth approach to improving outcomes for gout sufferers

Open Date: 2015-01-01

Close Date: 2020-01-01

Grant: Close

The first placebo-controlled trial of opioid analgesics for acute spinal pain

Open Date: 2015-01-01

Close Date: 2017-01-01

Grant: Close

Medicines and Ageing

Open Date: 2013-01-01

Close Date: 2018-01-01

Grant: Close

PRECISE: pregabalin in addition to usual care for sciatica

Open Date: 2013-01-01

Close Date: 2016-01-01

Grant: Close

A randomised controlled trial of deprescribing to optimise medical therapy for frail older people: the Opti-Med study.

Open Date: 2013-01-01

Close Date: 2016-01-01

Andrew McLachlan

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (28)

Consumer purchasing behaviour: oral contraceptives with Hypericum perforatum, and atorvastatin with Camellia sinensis: an Australia-wide basket analysis

Lidocaine for Neuropathic Cancer Pain (LiCPain): A Pilot Randomized Controlled Trial

Capabilities, opportunities and motivations within Australian community pharmacy to deliver clinical standard-aligned care for knee osteoarthritis: A mixed-methods evaluation

Green Tea Catechins as Perpetrators of Drug Pharmacokinetic Interactions

Effectiveness of interventions designed to increase safe medicine disposal: a systematic review and meta-analysis of randomised trials

Inter‐Ethnic Differences in the Efficacy and Safety of Tyrosine Kinase Inhibitors Used in Oncology: Insights From Phase 3 Clinical Trials

Developing a framework for managing conscientious objection in healthcare - Australia

Prevalence of heart failure pharmacotherapy utilisation, frailty and adverse drug events among hospitalised adults older than 75 years: a multicentre cross‐sectional study

Conscientious objection – a cross-sectional, vignette-based, mixed methods exploration of Australian pharmacists’ perspectives

Therapeutic drug monitoring of liposomal amphotericin B in children. Are we there yet? A systematic review

The effect of down‐titration and discontinuation of heart failure pharmacotherapy in older people: A systematic review and meta‐analysis

Efficacy and safety of antidepressants for pain in older adults: A systematic review and meta‐analysis

Policies and cost analyses of voluntary assisted dying (VAD) laws – a mapping review & analysis

Paracetamol Combination Therapy for Back Pain and Osteoarthritis: A Systematic Review and Meta-Analyses

Prescription and dispensing duration of medicines for hypertension and other chronic conditions: a review of international policies and evidence to inform the Australian setting

Opioid analgesics for nociceptive cancer pain: A comprehensive review

Efficacy, safety, and tolerability of antidepressants for pain in adults: overview of systematic reviews

Deprescribing interventions for gabapentinoids in adults: A scoping review

Conscientious objection – A vignette-based, pilot study of international pharmacists’ perspectives

Application of physiologically based pharmacokinetic modeling to understand real‐world outcomes in patients receiving imatinib for chronic myeloid leukemia

An evaluation of the quality of Annona muricata leaf products

Comparative effectiveness and safety of analgesic medicines for adults with acute non-specific low back pain: systematic review and network meta-analysis

Comparison of capecitabine concentrations determined by microsampling versus plasma concentrations for therapeutic drug monitoring: a pilot study

Editorial: National Medicines Policy 2.0—what’s changed and what’s next?

Physiologically Based Pharmacokinetic Modeling Approaches for Patients With SARS‐CoV‐2 Infection: A Case Study With Imatinib

Real‐world efficacy and safety outcomes of imatinib treatment in patients with chronic myeloid leukemia: An Australian experience

Immunomodulatory effects of pharmaceutical opioids and antipyretic analgesics: Mechanisms and relevance to infection

Osteoarthritis management: Does the pharmacist play a role in bridging the gap between what patients actually know and what they ought to know? Insights from a national online survey

Collaborators (25)

Christina Abdel Shaheed

Jennifer H. Martin

Richard O. Day

Alan Boddy

Chung-Wei Christine Lin

Matthew Jones

Martin Underwood

Tony Lai

Priyanka Vandersman

Jennifer Hunter

Betty B. Chaar

Stephanie Mathieson

Michael O. Falster

David Le Couteur

Jane Phillips

Meera Agar

Jane Rouse Hanrahan

David C Currow

Joanna Harnett

Sam Eldabe

Chris Hayes

Prunella Blinman

Justin Beardsley

Parisa Aslani

Nanna Finnerup

How do I reach out?

Meet Kite AI